197 related articles for article (PubMed ID: 31333452)
21. A Bayesian network meta-analysis on second-line systemic therapy in advanced gastric cancer.
Zhu X; Ko YJ; Berry S; Shah K; Lee E; Chan K
Gastric Cancer; 2017 Jul; 20(4):646-654. PubMed ID: 27722826
[TBL] [Abstract][Full Text] [Related]
22. Use of taxane-containing induction chemotherapy in combination with concurrent chemoradiotherapy in Chinese patients with locally advanced nasopharyngeal carcinoma: a meta-analysis.
Tian R; Ye HX; Zhang BG; Gu DY; Zhang BW; Teng ZP; Jin MY; Chen JF; Qi JW
Onco Targets Ther; 2015; 8():3255-63. PubMed ID: 26604792
[TBL] [Abstract][Full Text] [Related]
23. Effectiveness of an Adjuvant Chemotherapy Regimen for Early-Stage Breast Cancer: A Systematic Review and Network Meta-analysis.
Fujii T; Le Du F; Xiao L; Kogawa T; Barcenas CH; Alvarez RH; Valero V; Shen Y; Ueno NT
JAMA Oncol; 2015 Dec; 1(9):1311-8. PubMed ID: 26402167
[TBL] [Abstract][Full Text] [Related]
24. The clinical efficacy of cytotoxic agents in locally advanced or metastatic breast cancer patients pretreated with an anthracycline and a taxane: a systematic review.
Jassem J; Carroll C; Ward SE; Simpson E; Hind D
Eur J Cancer; 2009 Nov; 45(16):2749-58. PubMed ID: 19615886
[TBL] [Abstract][Full Text] [Related]
25. Taxanes as first-line therapy for advanced non-small cell lung cancer: a systematic review and practice guideline.
Chu Q; Vincent M; Logan D; Mackay JA; Evans WK;
Lung Cancer; 2005 Dec; 50(3):355-74. PubMed ID: 16139391
[TBL] [Abstract][Full Text] [Related]
26. A network meta-analysis of eight chemotherapy regimens for treatment of advanced ovarian cancer.
Jiang XP; Rui XH; Guo CX; Huang YQ; Li Q; Xu Y
Oncotarget; 2017 Mar; 8(12):19125-19136. PubMed ID: 27835912
[TBL] [Abstract][Full Text] [Related]
27. The Optimal Chinese Herbal Injections for Use With Radiotherapy to Treat Esophageal Cancer: A Systematic Review and Bayesian Network Meta-Analysis.
Zhang D; Ni M; Wu J; Liu S; Meng Z; Tian J; Zhang X; Zhang B
Front Pharmacol; 2018; 9():1470. PubMed ID: 30662402
[No Abstract] [Full Text] [Related]
28. The Efficacy and Safety of (Neo)Adjuvant Therapy for Gastric Cancer: A Network Meta-analysis.
van den Ende T; Ter Veer E; Machiels M; Mali RMA; Abe Nijenhuis FA; de Waal L; Laarman M; Gisbertz SS; Hulshof MCCM; van Oijen MGH; van Laarhoven HWM
Cancers (Basel); 2019 Jan; 11(1):. PubMed ID: 30641964
[No Abstract] [Full Text] [Related]
29. The efficacy and safety comparison of docetaxel, cabazitaxel, estramustine, and mitoxantrone for castration-resistant prostate cancer: A network meta-analysis.
Song P; Huang C; Wang Y
Int J Surg; 2018 Aug; 56():133-140. PubMed ID: 29906643
[TBL] [Abstract][Full Text] [Related]
30. Taxane containing regimens for metastatic breast cancer.
Ghersi D; Wilcken N; Simes J; Donoghue E
Cochrane Database Syst Rev; 2005 Apr; (2):CD003366. PubMed ID: 15846659
[TBL] [Abstract][Full Text] [Related]
31. Taxane containing regimens for metastatic breast cancer.
Ghersi D; Wilcken N; Simes J; Donoghue E
Cochrane Database Syst Rev; 2003; (3):CD003366. PubMed ID: 12917963
[TBL] [Abstract][Full Text] [Related]
32. Which are the best Chinese herbal injections combined with XELOX regimen for gastric cancer?: A PRISMA-compliant network meta-analysis.
Zhang D; Wu J; Wang K; Duan X; Liu S; Zhang B
Medicine (Baltimore); 2018 Mar; 97(12):e0127. PubMed ID: 29561411
[TBL] [Abstract][Full Text] [Related]
33. Induction regimens for transplant-eligible patients with newly diagnosed multiple myeloma: a network meta-analysis of randomized controlled trials.
Zeng ZH; Chen JF; Li YX; Zhang R; Xiao LF; Meng XY
Cancer Manag Res; 2017; 9():287-298. PubMed ID: 28744159
[TBL] [Abstract][Full Text] [Related]
34. Clinical efficacy and safety of Aidi injection plus paclitaxel-based chemotherapy for advanced non-small cell lung cancer: A meta-analysis of 31 randomized controlled trials following the PRISMA guidelines.
Xiao Z; Wang C; Zhou M; Hu S; Jiang Y; Huang X; Li N; Feng J; Tang F; Chen X; Ding J; Chen L; Wang Y; Li X
J Ethnopharmacol; 2019 Jan; 228():110-122. PubMed ID: 30243827
[TBL] [Abstract][Full Text] [Related]
35. How to maximize the efficacy of taxanes in breast cancer.
Tubiana-Hulin M
Cancer Treat Rev; 2005; 31 Suppl 4():S3-9. PubMed ID: 16360546
[TBL] [Abstract][Full Text] [Related]
36. Single-agent Taxane Versus Taxane-containing Combination Chemotherapy as Salvage Therapy for Advanced Urothelial Carcinoma.
Sonpavde G; Pond GR; Choueiri TK; Mullane S; Niegisch G; Albers P; Necchi A; Di Lorenzo G; Buonerba C; Rozzi A; Matsumoto K; Lee JL; Kitamura H; Kume H; Bellmunt J
Eur Urol; 2016 Apr; 69(4):634-641. PubMed ID: 26264159
[TBL] [Abstract][Full Text] [Related]
37. Comparative Efficacy of Treatments for Previously Treated Multiple Myeloma: A Systematic Literature Review and Network Meta-analysis.
Maiese EM; Ainsworth C; Le Moine JG; Ahdesmäki O; Bell J; Hawe E
Clin Ther; 2018 Mar; 40(3):480-494.e23. PubMed ID: 29500140
[TBL] [Abstract][Full Text] [Related]
38. A systematic literature review and network meta-analysis of effectiveness and safety outcomes in advanced melanoma.
Franken MG; Leeneman B; Gheorghe M; Uyl-de Groot CA; Haanen JBAG; van Baal PHM
Eur J Cancer; 2019 Dec; 123():58-71. PubMed ID: 31670077
[TBL] [Abstract][Full Text] [Related]
39. Docetaxel, cisplatin, and 5-fluorouracil compared with epirubicin, cisplatin, and 5-fluorouracil regimen for advanced gastric cancer: A systematic review and meta-analysis.
Li B; Chen L; Luo HL; Yi FM; Wei YP; Zhang WX
World J Clin Cases; 2019 Mar; 7(5):600-615. PubMed ID: 30863759
[TBL] [Abstract][Full Text] [Related]
40. Effectiveness and Safety of Oral Chinese Patent Medicines Combined with Chemotherapy for Gastric Cancer: A Bayesian Network Meta-Analysis.
Lu X; Zheng Y; Wen F; Huang W; Shu P
Evid Based Complement Alternat Med; 2020; 2020():8016531. PubMed ID: 32908569
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
